Mouse muscle as an ectopic permissive site for human pancreatic development

Diabetes

Volumn 62, Issue 10, 2013, Pages 3479-3487

  Capito, Carmen ^a   Simon, Marie Thérèse ^a   Aiello, Virginie ^a   Clark, Anne ^b   Aigrain, Yves ^c   Ravassard, Philippe ^d   Scharfmann, Raphael ^a  

^a INSERM   (France)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; GREEN FLUORESCENT PROTEIN; INSULIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN; NERVE PROTEIN; NEUROG3 PROTEIN, HUMAN; NEUROG3 PROTEIN, MOUSE; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ECTOPIC PANCREAS; ENGRAFTMENT; EPIMYSIUM; FEMALE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO GENE TRANSFER; KIDNEY CAPSULE; LENTIVIRINAE; LONGITUDINAL STUDY; MOUSE; MUSCLE GRAFT; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROMOTER REGION; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CYTOLOGY; ELECTRON MICROSCOPY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; METABOLISM; PANCREAS; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; TIME; EMBRYOLOGY;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TRANSFER TECHNIQUES; HOMEODOMAIN PROTEINS; HUMANS; ISLETS OF LANGERHANS; LENTIVIRUS; MICE; MICROSCOPY, ELECTRON; NERVE TISSUE PROTEINS; PANCREAS; PREGNANCY; TIME FACTORS; TRANS-ACTIVATORS;

EID: 84891537526     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0554     Document Type: Article

References (48)

1. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994;371:606-609
2. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997;15:106-110
3. Ohlsson H, Karlsson K, Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 1993;12:4251-4259
4. Bhushan A, Itoh N, Kato S, et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 2001;128:5109-5117
5. Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000;97:1607-1611
6. Desgraz R, Herrera PL. Pancreatic neurogenin 3-expressing cells are unipotent islet precursors. Development 2009;136:3567-3574
7. Oliver-Krasinski JM, Stoffers DA. On the origin of the beta cell. Genes Dev 2008;22:1998-2021
8. Schwitzgebel VM, Scheel DW, Conners JR, et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000;127:3533-3542
9. Sussel L, Kalamaras J, Hartigan-O'Connor DJ, et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998;125:2213-2221
10. Papizan JB, Singer RA, Tschen SI, et al. Nkx2.2 repressor complex regulates islet β-cell specification and prevents b-to-a-cell reprogramming. Genes Dev 2011;25:2291-2305
11. Pinney SE, Oliver-Krasinski J, Ernst L, et al. Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence. J Clin Endocrinol Metab 2011;96: 1960-1965
12. Rubio-Cabezas O, Jensen JN, Hodgson MI, et al. Permanent neonatal diabetes and enteric anendocrinosis associated with biallelic mutations in NEUROG3. Diabetes 2011;60:1349-1353
13. Dorrell C, Schug J, Lin CF, et al. Transcriptomes of the major human pancreatic cell types. Diabetologia 2011;54:2832-2844
14. Rodríguez-Seguí S, Akerman I, Ferrer J. GATA believe it: new essential regulators of pancreas development. J Clin Invest 2012;122:3469-3471
15. Carrasco M, Delgado I, Soria B, Martín F, Rojas A. GATA4 and GATA6 control mouse pancreas organogenesis. J Clin Invest 2012;122:3504-3515
16. Xuan S, Borok MJ, Decker KJ, et al. Pancreas-specific deletion of mouse Gata4 and Gata6 causes pancreatic agenesis. J Clin Invest 2012;122:3516-3528
17. Lango Allen H, Flanagan SE, Shaw-Smith C, et al.; International Pancreatic Agenesis Consortium. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet 2012;44:20-22
18. Rorsman P, Braun M. Regulation of insulin secretion in human pancreatic islets. Annu Rev Physiol 2013;75:155-179
19. Scharfmann R, Rachdi L, Ravassard P. Concise review: in search of unlimited sources of functional human pancreatic beta cells. Stem Cells Transl Med 2013;2:61-67
20. Tuch BE, Ng AB, Jones A, Turtle JR. Histologic differentiation of human fetal pancreatic explants transplanted into nude mice. Diabetes 1984;33: 1180-1187
21. Si Z, Tuch BE, Walsh DA. Development of human fetal pancreas after transplantation into SCID mice. Cells Tissues Organs 2001;168:147-157
22. Goldrath AW, Chen KE, Weide LG, Pour PM, Lebkowski JS, Alters SE. Retention of endocrine function in the SCID-Hu pancreas mouse-a model for the development of human fetal islet tissue. Transplantation 1995;59: 1497-1500
23. Castaing M, Péault B, Basmaciogullari A, Casal I, Czernichow P, Scharfmann R. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 2001;44:2066-2076
24. Polak M, Bouchareb-Banaei L, Scharfmann R, Czernichow P. Early pattern of differentiation in the human pancreas. Diabetes 2000;49:225-232
25. Attali M, Stetsyuk V, Basmaciogullari A, et al. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes 2007;56:1248-1258
26. Duvillié B, Attali M, Bounacer A, Ravassard P, Basmaciogullari A, Scharfmann R. The mesenchyme controls the timing of pancreatic betacell differentiation. Diabetes 2006;55:582-589
27. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci USA 1994;91:9253-9256
28. Castaing M, Guerci A, Mallet J, Czernichow P, Ravassard P, Scharfmann R. Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells. Diabetologia 2005;48: 709-719
29. Davalli AM, Ogawa Y, Ricordi C, Scharp DW, Bonner-Weir S, Weir GC. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 1995;59:817-820
30. Montaña E, Bonner-Weir S, Weir GC. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J Clin Invest 1993;91:780-787
31. De Krijger RR, Aanstoot HJ, Kranenburg G, Reinhard M, Visser WJ, Bruining GJ. The midgestational human fetal pancreas contains cells coexpressing islet hormones. Dev Biol 1992;153:368-375
32. Riedel MJ, Asadi A, Wang R, Ao Z, Warnock GL, Kieffer TJ. Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas. Diabetologia 2012;55:372-381
33. Gittes GK. Developmental biology of the pancreas: a comprehensive review. Dev Biol 2009;326:4-35
34. Rafael E, Tibell A, Rydén M, et al. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant 2008;8:458-462
35. Christoffersson G, Henriksnäs J, Johansson L, et al. Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes 2010;59: 2569-2578
36. Lund T, Korsgren O, Aursnes IA, Scholz H, Foss A. Sustained reversal of diabetes following islet transplantation to striated musculature in the rat. J Surg Res 2010;160:145-154
37. Sterkers A, Hubert T, Gmyr V, et al. Islet survival and function following intramuscular autotransplantation in the minipig. Am J Transplant 2013;13: 891-898
38. Pattou F, Kerr-Conte J, Wild D. GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle. N Engl J Med 2010;363:1289-1290
39. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormoneexpressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006;24:1392-1401
40. Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulinsecreting cells in vivo. Nat Biotechnol 2008;26:443-452
41. Jacobs-Tulleneers-Thevissen D, Bartholomeus K, Suenens K, et al. Human islet cell implants in a nude rat model of diabetes survive better in omentum than in liver with a positive influence of beta cell number and purity. Diabetologia 2010;53:1690-1699
42. Jensen J, Heller RS, Funder-Nielsen T, et al. Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes 2000;49:163-176
43. Heimberg H, Bouwens L, Heremans Y, Van De Casteele M, Lefebvre V, Pipeleers D. Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes 2000;49:571-579
44. Sun Y, Pollard S, Conti L, et al. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci 2008;38:245-258
45. Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. Clin Invest 2004;114:963-968
46. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000;49:1325-1333
47. Meier JJ, Butler AE, Saisho Y, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008;57:1584-1594
48. Chen H, Gu X, Liu Y, et al. PDGF signalling controls age-dependent proliferation in pancreatic b-cells. Nature 2011;478:349-355